In PAH with high risk for death, sotatercept reduced a composite of death, lung transplantation, or PAH hospitalization >24 h at 9 mo.
Where this comes from
- Record sourced from PubMed, PMID 40759015.
- Also identified by DOI 10.7326/ANNALS-25-02887-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP: [Formula: see text] Pulmonology: [Formula: see text].
Medical subject headings
- Lung Transplantation
- Hospitalization
- Recombinant Fusion Proteins
- Pulmonary Arterial Hypertension